Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2008

01.12.2008 | Research Article

Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria

verfasst von: Kazeem B. Yusuff, Olubunmi Obe, Bonatson Y. Joseph

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective To describe the pattern of anti-diabetic drug prescribing; ascertain the level of glycemic control, adherence with prescribed anti-diabetic medications, and diabetes self management practices among patients with type-2 diabetes in a tertiary care setting in Nigeria. Setting University College Hospital (UCH); a 900 bed teaching hospital with medical residents located in Ibadan, southwestern Nigeria. Method The study consisted of two phases. A cross-sectional review of randomly selected 200 case notes of type 2 diabetic patients that attended the Endocrinology clinic over 3 month; and crosssectional interviews, with a pre-tested Adherence and Self-Management Monitoring Tool (ASMMT), of 200 consecutive patients that presented their drug prescriptions at the satellite pharmacy unit over a 4 week period at a 900-bed teaching hospital located in Ibadan, South-Western Nigeria. Results Oral Hypoglycemic Agents (OHA) were prescribed for 86% (171) of cohorts while insulin and OHA was prescribed in 14% (29). About 70.8% (121) of patients on OHA were on combination therapy. The most frequently prescribed OHA combination was glibenclamide and metformin (95.8%). Glibenclamide was prescribed as twice daily regimen in 69% of cohorts. The most frequently documented side effect was hypoglycemia (60.3%). Only 44% (88) of cohorts had adequate glycemic control; of these, 93% (82) were adjudged adherent with prescribed anti-diabetic drugs. Interviews with the structured ASMMT revealed that 59% of patients were non-adherent with the previous anti-diabetic drugs due to lack of finance (51.7%); side effects (34.5%); perceived inefficacy of prescribed anti-diabetic drugs leading to self-medication with local herbs (13.8%). Only 20% of non-adherent patients claimed disclosure to physicians during consultation. The identified factors for non-disclosure were lack of privacy during consultation (58%); and short consultation time (42%). The knowledge and practice of critical components of diabetes self-management behaviours were generally low among the cohort studied. However, it was significantly higher among patient judged adherent with their prescribed anti-diabetic medications (P < 0.05). Conclusion Majority of patients with type 2 diabetes in an ambulatory tertiary care setting in Nigeria are managed with OHA combinations, mainly glibenclamide and metformin. While the current prescribing strategy achieved glycemic control in about one third of patients, majority are still not meeting the recommended blood glucose targets due to poor adherence with prescribed drug regimen, and poor knowledge and practice of successful self-management.
Literatur
1.
Zurück zum Zitat King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025. Diabetes Care. 1998;21:1414–31.PubMedCrossRef King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025. Diabetes Care. 1998;21:1414–31.PubMedCrossRef
3.
Zurück zum Zitat Haffner SM, Lehto S, Ronnemma T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.PubMedCrossRef Haffner SM, Lehto S, Ronnemma T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.PubMedCrossRef
4.
Zurück zum Zitat Russell RB, Valiyeva E, Roman SH, Pogach LM, Suh D, Safford MM. Hospitalization, nursing home admission and deaths attributable to diabetes. Diabetes Care. 2005;28:1611–7.PubMedCrossRef Russell RB, Valiyeva E, Roman SH, Pogach LM, Suh D, Safford MM. Hospitalization, nursing home admission and deaths attributable to diabetes. Diabetes Care. 2005;28:1611–7.PubMedCrossRef
5.
Zurück zum Zitat Beckman JA, Creager MQ, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570–81.PubMedCrossRef Beckman JA, Creager MQ, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570–81.PubMedCrossRef
6.
Zurück zum Zitat Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. Br Med J. 2006;332:73–8.CrossRef Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. Br Med J. 2006;332:73–8.CrossRef
7.
Zurück zum Zitat Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7.PubMedCrossRef Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7.PubMedCrossRef
8.
Zurück zum Zitat American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care. 1999;22:S27–31.CrossRef American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care. 1999;22:S27–31.CrossRef
9.
Zurück zum Zitat Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA. 1996;276:1409–15.CrossRef Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA. 1996;276:1409–15.CrossRef
10.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef
11.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–65.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–65.CrossRef
12.
Zurück zum Zitat Cohen FJ, Conklin JE, Neslusan CA, Song X. Recent antihyperglyceamic prescribing trends for US privately insured patients with type 2 diabetes. Diabetes Care. 2003;26(6):1847–51.PubMedCrossRef Cohen FJ, Conklin JE, Neslusan CA, Song X. Recent antihyperglyceamic prescribing trends for US privately insured patients with type 2 diabetes. Diabetes Care. 2003;26(6):1847–51.PubMedCrossRef
13.
Zurück zum Zitat Turner RC, Cull CA, Fright V, Holman RR, for the UK Prospective Diabetes Study (UKPDS) Group. Glycemic control with diet, sulfonylurea, metformin or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies. JAMA. 1999;281:2005–12. Turner RC, Cull CA, Fright V, Holman RR, for the UK Prospective Diabetes Study (UKPDS) Group. Glycemic control with diet, sulfonylurea, metformin or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies. JAMA. 1999;281:2005–12.
14.
Zurück zum Zitat Defronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 1999;131:281–303.PubMed Defronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 1999;131:281–303.PubMed
15.
Zurück zum Zitat Chuang LM, Tsai ST, Huang BY, Tai TY; Diabcare-Asia 1998 Study Group. The status of diabetes control in Asia- a cross-sectional survey of 24,317 patients with diabetes mellitus in 1998. Diabetes Med. 2002;19:978–85. Chuang LM, Tsai ST, Huang BY, Tai TY; Diabcare-Asia 1998 Study Group. The status of diabetes control in Asia- a cross-sectional survey of 24,317 patients with diabetes mellitus in 1998. Diabetes Med. 2002;19:978–85.
16.
Zurück zum Zitat Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27(1):17–20.PubMedCrossRef Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27(1):17–20.PubMedCrossRef
17.
Zurück zum Zitat Wong JS, Rahimah N. Glycemic control of diabetic patients in an urban primary health care setting in Sarawak: the Tanah Putch Health Centre experience. Med J Malaysia. 2004;59(3):411–7.PubMed Wong JS, Rahimah N. Glycemic control of diabetic patients in an urban primary health care setting in Sarawak: the Tanah Putch Health Centre experience. Med J Malaysia. 2004;59(3):411–7.PubMed
18.
Zurück zum Zitat El-Kebbi IM, Gallina DL, Ziemer DC, et al. Diabetes in urban African-Americans. VI. Utility of fasting or random glucose in identifying poor glycemic control. Diabetes Care. 1998;21(4):501–7.PubMedCrossRef El-Kebbi IM, Gallina DL, Ziemer DC, et al. Diabetes in urban African-Americans. VI. Utility of fasting or random glucose in identifying poor glycemic control. Diabetes Care. 1998;21(4):501–7.PubMedCrossRef
19.
Zurück zum Zitat Ndububa DA, Erhabor GE. Diabetic mortalities in Ilesa, Nigeria: a retrospective study. Cent Afr J Med. 1994;40(10):28–9. Ndububa DA, Erhabor GE. Diabetic mortalities in Ilesa, Nigeria: a retrospective study. Cent Afr J Med. 1994;40(10):28–9.
20.
Zurück zum Zitat Puepet FH, Agaba EI, Chuhwak EK. Some metabolic abnormalities in type 2 diabetic patients in Jos, north central Nigeria. Niger J Med. 2003;12(4):193–7.PubMed Puepet FH, Agaba EI, Chuhwak EK. Some metabolic abnormalities in type 2 diabetic patients in Jos, north central Nigeria. Niger J Med. 2003;12(4):193–7.PubMed
21.
Zurück zum Zitat Alebiosu CO. Clinical diabetic neuropathy in a tropical African population. West Afr J Med. 2003;22(2):152–5.PubMed Alebiosu CO. Clinical diabetic neuropathy in a tropical African population. West Afr J Med. 2003;22(2):152–5.PubMed
22.
Zurück zum Zitat Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care. 2004;27:2444–9.PubMedCrossRef Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care. 2004;27:2444–9.PubMedCrossRef
23.
Zurück zum Zitat Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–9.PubMedCrossRef Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–9.PubMedCrossRef
24.
Zurück zum Zitat Sullivan PW, Morrato EH, Ghushehyan V, et al. Obesity, inactivity and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the US, 2000–2002. Diabetes Care. 2005;28:1599–603.PubMedCrossRef Sullivan PW, Morrato EH, Ghushehyan V, et al. Obesity, inactivity and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the US, 2000–2002. Diabetes Care. 2005;28:1599–603.PubMedCrossRef
25.
Zurück zum Zitat American Diabetes Association (ADA). Standard of medical care in diabetes. Diabetes Care. 2005;28:S10–20.CrossRef American Diabetes Association (ADA). Standard of medical care in diabetes. Diabetes Care. 2005;28:S10–20.CrossRef
26.
Zurück zum Zitat Barnett AH. Treating to goal: challenges of current management. Eur J Endocrinol. 2004;151:T3–7.PubMedCrossRef Barnett AH. Treating to goal: challenges of current management. Eur J Endocrinol. 2004;151:T3–7.PubMedCrossRef
27.
Zurück zum Zitat Harrower AD. Comparative tolerability of sulphonylureas in diabetes mellitus. Drug Saf. 2000;22(4):313–20.PubMedCrossRef Harrower AD. Comparative tolerability of sulphonylureas in diabetes mellitus. Drug Saf. 2000;22(4):313–20.PubMedCrossRef
28.
Zurück zum Zitat British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary, March 2005. London: BMJ Publishing Group and Royal Pharmaceutical Society of Great Britain; 2005. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary, March 2005. London: BMJ Publishing Group and Royal Pharmaceutical Society of Great Britain; 2005.
29.
Zurück zum Zitat American Society of Health-System Pharmacists/American Hospital Formulary Services (ASHP/AHFS). AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 2002. American Society of Health-System Pharmacists/American Hospital Formulary Services (ASHP/AHFS). AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 2002.
30.
Zurück zum Zitat Wan Mohamad WB, Tun Fizi A, Ismail RB, Mafauzy M. Efficacy and safety of Single versus multiple daily doses of glibenclamide in type 2 diabetes mellitus. Diabetes Res. 2000;49(2):93–9.CrossRef Wan Mohamad WB, Tun Fizi A, Ismail RB, Mafauzy M. Efficacy and safety of Single versus multiple daily doses of glibenclamide in type 2 diabetes mellitus. Diabetes Res. 2000;49(2):93–9.CrossRef
31.
Zurück zum Zitat Marre M, Howlett H, Lehert P, Allavoine T. Improved glycemic control with metformin–glibenclamide combined tablet therapy in type 2 diabetic patients inadequately controlled on metformin. Diabet Med. 2002;19(8):673–80.PubMedCrossRef Marre M, Howlett H, Lehert P, Allavoine T. Improved glycemic control with metformin–glibenclamide combined tablet therapy in type 2 diabetic patients inadequately controlled on metformin. Diabet Med. 2002;19(8):673–80.PubMedCrossRef
32.
Zurück zum Zitat Melikian C, White TJ, Vanderplas A, Dezii CM, Chang E. Adherence to oral antidiabetic therapy in amanged care organization: a comparison of monotherapy, combination therapy and fixed-dose combination therapy. Clin Ther. 2002;24(3):460–7.PubMedCrossRef Melikian C, White TJ, Vanderplas A, Dezii CM, Chang E. Adherence to oral antidiabetic therapy in amanged care organization: a comparison of monotherapy, combination therapy and fixed-dose combination therapy. Clin Ther. 2002;24(3):460–7.PubMedCrossRef
33.
Zurück zum Zitat Erasmus RT, Blanco B, Okesina AB, Gqweta Z, Matsha T. Assessment of glycemic control in stable type 2 black south African diabetics attending a peri-urban clinic. Postgrad Med J. 1999;75:603–6.PubMed Erasmus RT, Blanco B, Okesina AB, Gqweta Z, Matsha T. Assessment of glycemic control in stable type 2 black south African diabetics attending a peri-urban clinic. Postgrad Med J. 1999;75:603–6.PubMed
34.
Zurück zum Zitat Kolawole BA, Adegbenro C, Ayoola ZO, Opebiyi B. Diabetes mellitus related treatment goals: awareness and attainment in the Ife-Ijesha zone of south-western Nigeria. Afr J Med Med Sci. 2005;34(4):389–94. Kolawole BA, Adegbenro C, Ayoola ZO, Opebiyi B. Diabetes mellitus related treatment goals: awareness and attainment in the Ife-Ijesha zone of south-western Nigeria. Afr J Med Med Sci. 2005;34(4):389–94.
35.
Zurück zum Zitat United Nation Development Programme (UNDP). Eye of the needle—Nigeria 2000. New York, USA: Human Development Reports; 2000. United Nation Development Programme (UNDP). Eye of the needle—Nigeria 2000. New York, USA: Human Development Reports; 2000.
36.
Zurück zum Zitat Seltzer HS. Drug induced hypoglycemia. Endocrinol Metab Clin North Am. 1989;18:163–83.PubMed Seltzer HS. Drug induced hypoglycemia. Endocrinol Metab Clin North Am. 1989;18:163–83.PubMed
37.
Zurück zum Zitat Talabi OA. A questionnaire survey of senior house officers/registrars response to their training at University College Hospital, Ibadan. West Afr J Med. 2003;22(2):108–11. Talabi OA. A questionnaire survey of senior house officers/registrars response to their training at University College Hospital, Ibadan. West Afr J Med. 2003;22(2):108–11.
38.
Zurück zum Zitat Ndom RJE, Makanjuola AB. Perceived stress factors among resident doctors in a Nigerian teaching hospital. West Afr J Med. 2004;23(3):78–81. Ndom RJE, Makanjuola AB. Perceived stress factors among resident doctors in a Nigerian teaching hospital. West Afr J Med. 2004;23(3):78–81.
39.
Zurück zum Zitat Ajayi IO, Olumide EA, Oyediran O. Patient satisfaction with the services provided at a general outpatient clinic, Ibadan, Oyo state, Nigeria. Afr J Med Med Sci. 2005;34:133–40.PubMed Ajayi IO, Olumide EA, Oyediran O. Patient satisfaction with the services provided at a general outpatient clinic, Ibadan, Oyo state, Nigeria. Afr J Med Med Sci. 2005;34:133–40.PubMed
40.
Zurück zum Zitat Glasgow RE, Strycker LA, Hampson SE, Ruggiero L. Personal model beliefs and social-environmental barriers related to diabetes self-management. Diabetes Care. 1997;20:556–61.PubMedCrossRef Glasgow RE, Strycker LA, Hampson SE, Ruggiero L. Personal model beliefs and social-environmental barriers related to diabetes self-management. Diabetes Care. 1997;20:556–61.PubMedCrossRef
41.
Zurück zum Zitat Day JL. Diabetic patients education: determinants of success. Diabetes Metab Res Rev. 2000;16(Supl 1):S70–4.PubMedCrossRef Day JL. Diabetic patients education: determinants of success. Diabetes Metab Res Rev. 2000;16(Supl 1):S70–4.PubMedCrossRef
42.
Zurück zum Zitat Campbell RK. Role of the pharmacists in diabetes management. Am J Health Syst Pharm. 2002;59(9):18–21. Campbell RK. Role of the pharmacists in diabetes management. Am J Health Syst Pharm. 2002;59(9):18–21.
43.
Zurück zum Zitat Acheampong JW, Boateng KA, Eghan BA, Story P, Parry EHO, Tomlinson S. The impact of diabetes nurses in the Komfo Anokye Teaching Hospital, Ghana. Diabetes Int. 2000;10:81–3. Acheampong JW, Boateng KA, Eghan BA, Story P, Parry EHO, Tomlinson S. The impact of diabetes nurses in the Komfo Anokye Teaching Hospital, Ghana. Diabetes Int. 2000;10:81–3.
44.
Zurück zum Zitat Berthoet N, Favrat B, Fallab-Stubi CL, Brunner HR, Burnier M. Why objective monitoring of compliance is important in management of hypertension. J Clin Hypertens. 2000;2:210–4. Berthoet N, Favrat B, Fallab-Stubi CL, Brunner HR, Burnier M. Why objective monitoring of compliance is important in management of hypertension. J Clin Hypertens. 2000;2:210–4.
45.
Zurück zum Zitat Fodor GJ, Kotrec M, BacsKai K, et al. Is interview a reliable method to verify compliance with antihypertensive therapy? An international central-European study. J Hum Hypertens. 2005;23:1261–6. Fodor GJ, Kotrec M, BacsKai K, et al. Is interview a reliable method to verify compliance with antihypertensive therapy? An international central-European study. J Hum Hypertens. 2005;23:1261–6.
46.
Zurück zum Zitat Yusuff KB, Alabi A. Assessing patient adherence to anti-hypertensive drug therapy: can a structured pharmacist-conducted interview separate the wheat from the chaff? Int J Pharm Pract. 2007;15:295–300.CrossRef Yusuff KB, Alabi A. Assessing patient adherence to anti-hypertensive drug therapy: can a structured pharmacist-conducted interview separate the wheat from the chaff? Int J Pharm Pract. 2007;15:295–300.CrossRef
Metadaten
Titel
Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria
verfasst von
Kazeem B. Yusuff
Olubunmi Obe
Bonatson Y. Joseph
Publikationsdatum
01.12.2008
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2008
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-008-9243-2

Weitere Artikel der Ausgabe 6/2008

International Journal of Clinical Pharmacy 6/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Gegen postoperative Darmmotilitätsstörung: Erster Kaffee schon im Aufwachraum

30.04.2024 DCK 2024 Kongressbericht

Nach einer Operation kann es zu einer vorübergehenden Störung der Darmmotilität kommen, ohne dass es eine mechanische Ursache gibt. Auf eine postoperative Darmmotilitätsstörung weist besonders hin, wenn Nahrung oral nicht toleriert wird.

Frauen bekommen seltener eine intensive Statintherapie

30.04.2024 Statine Nachrichten

Frauen in den Niederlanden erhalten bei vergleichbarem kardiovaskulärem Risiko seltener eine intensive Statintherapie als Männer. Ihre LDL-Zielwerte erreichen sie aber fast ähnlich oft.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.